Gilead Sciences Valuation
| GILD34 Stock | BRL 287.56 4.47 1.58% |
At this time, the firm appears to be undervalued. Gilead Sciences retains a regular Real Value of R$321.17 per share. The prevalent price of the firm is R$287.56. Our model calculates the value of Gilead Sciences from evaluating the firm fundamentals such as Return On Equity of 0.22, current valuation of 686.18 B, and Return On Asset of 0.1 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Gilead Sciences' price fluctuation is very steady at this time. Calculation of the real value of Gilead Sciences is based on 3 months time horizon. Increasing Gilead Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Gilead Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gilead Stock. However, Gilead Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 287.56 | Real 321.17 | Hype 287.56 |
The real value of Gilead Stock, also known as its intrinsic value, is the underlying worth of Gilead Sciences Company, which is reflected in its stock price. It is based on Gilead Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Gilead Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Gilead Sciences helps investors to forecast how Gilead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gilead Sciences more accurately as focusing exclusively on Gilead Sciences' fundamentals will not take into account other important factors: Gilead Sciences Total Value Analysis
Gilead Sciences is currently expected to have takeover price of 686.18 B with market capitalization of 572.2 B, debt of 25.18 B, and cash on hands of 28.36 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Gilead Sciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
686.18 B | 572.2 B | 25.18 B | 28.36 B |
Gilead Sciences Investor Information
The company has Price/Earnings To Growth (PEG) ratio of 0.71. Gilead Sciences recorded earning per share (EPS) of 9.63. The entity last dividend was issued on the 14th of March 2023. Based on the key indicators related to Gilead Sciences' liquidity, profitability, solvency, and operating efficiency, Gilead Sciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Gilead Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Gilead Sciences has an asset utilization ratio of 43.19 percent. This suggests that the Company is making R$0.43 for each dollar of assets. An increasing asset utilization means that Gilead Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Gilead Sciences Profitability Analysis
The company reported the revenue of 27.28 B. Net Income was 4.59 B with profit before overhead, payroll, taxes, and interest of 21.62 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Gilead Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Gilead Sciences and how it compares across the competition.
About Gilead Sciences Valuation
The stock valuation mechanism determines Gilead Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Gilead Sciences. We calculate exposure to Gilead Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gilead Sciences's related companies.Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company was founded in 1987 and is headquartered in Foster City, California. GILEAD DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 11000 people.
8 Steps to conduct Gilead Sciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Gilead Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Gilead Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Gilead Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Gilead Sciences' revenue streams: Identify Gilead Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Gilead Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Gilead Sciences' growth potential: Evaluate Gilead Sciences' management, business model, and growth potential.
- Determine Gilead Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Gilead Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |